185 related articles for article (PubMed ID: 20360255)
1. Regulation of cardiomyocyte polyploidy and multinucleation by CyclinG1.
Liu Z; Yue S; Chen X; Kubin T; Braun T
Circ Res; 2010 May; 106(9):1498-506. PubMed ID: 20360255
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyocyte cell cycle control and growth estimation in vivo--an analysis based on cardiomyocyte nuclei.
Walsh S; Pontén A; Fleischmann BK; Jovinge S
Cardiovasc Res; 2010 Jun; 86(3):365-73. PubMed ID: 20071355
[TBL] [Abstract][Full Text] [Related]
3. Endothelial nitric oxide synthase promotes neonatal cardiomyocyte proliferation by inhibiting tissue inhibitor of metalloproteinase-3 expression.
Hammoud L; Xiang F; Lu X; Brunner F; Leco K; Feng Q
Cardiovasc Res; 2007 Jul; 75(2):359-68. PubMed ID: 17553475
[TBL] [Abstract][Full Text] [Related]
4. Survivin determines cardiac function by controlling total cardiomyocyte number.
Levkau B; Schäfers M; Wohlschlaeger J; von Wnuck Lipinski K; Keul P; Hermann S; Kawaguchi N; Kirchhof P; Fabritz L; Stypmann J; Stegger L; Flögel U; Schrader J; Fischer JW; Hsieh P; Ou YL; Mehrhof F; Tiemann K; Ghanem A; Matus M; Neumann J; Heusch G; Schmid KW; Conway EM; Baba HA
Circulation; 2008 Mar; 117(12):1583-93. PubMed ID: 18332262
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptor 1 gene expression is required for cardiomyocyte proliferation and is repressed by Sp3.
Seyed M; Dimario JX
J Mol Cell Cardiol; 2008 Mar; 44(3):510-9. PubMed ID: 18275970
[TBL] [Abstract][Full Text] [Related]
6. E2F2 expression induces proliferation of terminally differentiated cardiomyocytes in vivo.
Ebelt H; Zhang Y; Kampke A; Xu J; Schlitt A; Buerke M; Müller-Werdan U; Werdan K; Braun T
Cardiovasc Res; 2008 Nov; 80(2):219-26. PubMed ID: 18628254
[TBL] [Abstract][Full Text] [Related]
7. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A
Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806
[TBL] [Abstract][Full Text] [Related]
8. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
9. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy.
Nelson TJ; Balza R; Xiao Q; Misra RP
J Mol Cell Cardiol; 2005 Sep; 39(3):479-89. PubMed ID: 15950986
[TBL] [Abstract][Full Text] [Related]
10. Directed expression of dominant-negative p73 enables proliferation of cardiomyocytes in mice.
Ebelt H; Zhang Y; Köhler K; Xu J; Gajawada P; Boettger T; Hollemann T; Müller-Werdan U; Werdan K; Braun T
J Mol Cell Cardiol; 2008 Sep; 45(3):411-9. PubMed ID: 18634800
[TBL] [Abstract][Full Text] [Related]
11. Cyclin I and p53 are differentially expressed during the terminal differentiation of the postnatal mouse heart.
Liu Y; Tang MK; Cai DQ; Li M; Wong WM; Chow PH; Lee KK
Proteomics; 2007 Jan; 7(1):23-32. PubMed ID: 17154274
[TBL] [Abstract][Full Text] [Related]
12. The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy.
Buitrago M; Lorenz K; Maass AH; Oberdorf-Maass S; Keller U; Schmitteckert EM; Ivashchenko Y; Lohse MJ; Engelhardt S
Nat Med; 2005 Aug; 11(8):837-44. PubMed ID: 16025126
[TBL] [Abstract][Full Text] [Related]
13. [Polyploidization mechanisms of the cardiac myocytes in the mouse].
Uryvaeva IV; Aref'rva AM; Brodskiĭ VIa
Biull Eksp Biol Med; 1980 Feb; 89(2):219-22. PubMed ID: 7370428
[TBL] [Abstract][Full Text] [Related]
14. TWEAK is a positive regulator of cardiomyocyte proliferation.
Novoyatleva T; Diehl F; van Amerongen MJ; Patra C; Ferrazzi F; Bellazzi R; Engel FB
Cardiovasc Res; 2010 Mar; 85(4):681-90. PubMed ID: 19887380
[TBL] [Abstract][Full Text] [Related]
15. Polyploidy in Cardiomyocytes: Roadblock to Heart Regeneration?
Derks W; Bergmann O
Circ Res; 2020 Feb; 126(4):552-565. PubMed ID: 32078450
[TBL] [Abstract][Full Text] [Related]
16. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
17. miR-488-3p Protects Cardiomyocytes against Doxorubicin-Induced Cardiotoxicity by Inhibiting CyclinG1.
Yan M; Cao Y; Wang Q; Xu K; Dou L; Huang X; Chen B; Tang W; Lan M; Liu B; Zhu K; Yang Y; Sun S; Zhang X; Man Y; Hei M; Shen T; Li J
Oxid Med Cell Longev; 2022; 2022():5184135. PubMed ID: 35186188
[TBL] [Abstract][Full Text] [Related]
18. miR133a regulates cardiomyocyte hypertrophy in diabetes.
Feng B; Chen S; George B; Feng Q; Chakrabarti S
Diabetes Metab Res Rev; 2010 Jan; 26(1):40-9. PubMed ID: 20013939
[TBL] [Abstract][Full Text] [Related]
19. Propranolol promotes Egr1 gene expression in cardiomyocytes via beta-adrenoceptors.
Patrizio M; Musumeci M; Stati T; Fecchi K; Mattei E; Catalano L; Marano G
Eur J Pharmacol; 2008 Jun; 587(1-3):85-9. PubMed ID: 18485346
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy.
Busk PK; Hinrichsen R; Bartkova J; Hansen AH; Christoffersen TE; Bartek J; Haunsø S
Exp Cell Res; 2005 Mar; 304(1):149-61. PubMed ID: 15707582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
